PMC:7239617 / 6084-6850
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 258 | 50-58 | Species | denotes | patients | Tax:9606 |
| 259 | 468-476 | Species | denotes | patients | Tax:9606 |
| 260 | 663-671 | Species | denotes | patients | Tax:9606 |
| 261 | 183-193 | Chemical | denotes | β-D-glucan | |
| 262 | 304-317 | Chemical | denotes | galactomannan | MESH:C012990 |
| 263 | 625-638 | Chemical | denotes | Galactomannan | MESH:C012990 |
| 264 | 625-638 | Chemical | denotes | Galactomannan | MESH:C012990 |
| 265 | 682-700 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 266 | 81-89 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 267 | 508-532 | Disease | denotes | Aspergillus invasiveness | MESH:D001228 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T13 | 197-202 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T14 | 215-220 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T15 | 412-417 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T13 | 197-202 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T14 | 215-220 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T15 | 412-417 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T41 | 141-144 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
| T42 | 542-545 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T62 | 81-89 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T50 | 21-30 | http://www.ebi.ac.uk/efo/EFO_0000876 | denotes | extremely |
| T51 | 318-325 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T52 | 489-490 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T53 | 727-728 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T81 | 13-16 | Chemical | denotes | BAL | http://purl.obolibrary.org/obo/CHEBI_64198 |
| T82 | 141-144 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
| T84 | 187-193 | Chemical | denotes | glucan | http://purl.obolibrary.org/obo/CHEBI_37163 |
| T85 | 288-291 | Chemical | denotes | BAL | http://purl.obolibrary.org/obo/CHEBI_64198 |
| T86 | 304-317 | Chemical | denotes | galactomannan | http://purl.obolibrary.org/obo/CHEBI_27680 |
| T87 | 418-431 | Chemical | denotes | galactomannan | http://purl.obolibrary.org/obo/CHEBI_27680 |
| T88 | 542-545 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
| T90 | 682-700 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-PD-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
|---|---|---|---|---|---|
| T6 | 304-317 | GlycoEpitope | denotes | galactomannan | http://www.glycoepitope.jp/epitopes/EP0510 |
| T7 | 418-431 | GlycoEpitope | denotes | galactomannan | http://www.glycoepitope.jp/epitopes/EP0510 |
| T8 | 625-638 | GlycoEpitope | denotes | Galactomannan | http://www.glycoepitope.jp/epitopes/EP0510 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T52 | 0-155 | Sentence | denotes | Since CT and BAL are extremely difficult to do in patients with life-threatening COVID-19, mycological data collection is essential to allow IPA diagnosis. |
| T53 | 156-411 | Sentence | denotes | We strongly support adding β-D-glucan in serum and qPCR in serum and respiratory specimens to the accepted mycological work-up (ie, BAL culture and galactomannan testing)4, 6 until the most sensitive and specific biomarkers are identified in this setting. |
| T54 | 412-624 | Sentence | denotes | Serum galactomannan was negative in eight of nine (89%) patients, suggesting a lesser degree of Aspergillus invasiveness or early IPA diagnosis, since respiratory specimens were obtained shortly after intubation. |
| T55 | 625-766 | Sentence | denotes | Galactomannan was negative in our two patients receiving hydroxychloroquine, which is thought to have a negative effect on this measurement.9 |